|
|
ED-71市场分析报告
|
CAS 104121-92-8 Eldecalcitol Chemical Report & Database ... Consumption Report & Database definitions: Name: Eldecalcitol: Eldecalcitol; ED-71; 2-(3-Hydroxypropoxy)-1,25-dihydroxyvitamin D3 Synonyms: ED-71; 2-(3- ... : Chemical or Reaction Intermediate The Eldecalcitol Report & Database gives Market ...
Global Eldecalcitol Generics Market Growth 2024-2030 ... global companies with a focus on Eldecalcitol Generics portfolios and capabilities, ... . United States market for Eldecalcitol Generics is estimated to increase from US$ million ... shares, and growth opportunities of Eldecalcitol Generics market by product type ...
Global Eldecalcitol Soft Capsules Market Growth 2024-2030 ... after order is placed. Eldecalcitol soft capsules contain eldecalcitol,a synthetic derivative of ... analysis in US$ millions of the world Eldecalcitol Soft Capsules industry. This ... a comprehensive analysis of the global Eldecalcitol Soft Capsules landscape and ...
Taisho Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... Pharmaceutical Co., Ltd. to co-develop and co-market ED-71 (eldecalcitol), an activated vitamin D derivative that Chugai ...
Global Market Report of 2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3 (CAS 104121-92-8) December 2024
Vitamin China E-News 2010 (12 issues per year) ... Chemexpress noticed on 28 Sept. that its eldecalcitol and intermediate project gained outstanding ...
Research Report on China Osteoporosis Drug Market, 2013-2017 ... in China yet, such as bazedoxifene acetate, eldecalcitol and some prolonged action preparations ...
Vitamin China E-News ... on the Shanghai Stock Exchange, with eldecalcitol being one of its planned products ...
Global Postmenopausal Osteoporosis Treatment Market Size study & Forecast, by Drug Type (Bisphosphonates, Vitamin D3, Estrogen Agonist/Antagonist, Hormone Replacement Therapy, Parathyroid Hormone Therapy, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) and Regional Analysis, 2023-2030 ... of Chugai Pharmaceutical Co., Ltd., launched Edirol (eldecalcitol) in China after receiving permission from ...
Chugai Pharmaceutical Co., Ltd. - Company Profile and SWOT Analysis ... mofetil), Tamiflu (oseltamivir phosphate), Edirol (eldecalcitol), Kadcyla (trastuzumab emtansine), Kytril, and ...
|
|
|
|